astrazeneca annual report 2010
Dividend Summary. The all-time high AstraZeneca stock closing price was 61.10 on July 17, 2020.; The AstraZeneca 52-week high stock price is 64.94, which is 29.8% above the current share price. AstraZeneca sold a stake it held in rival COVID-19 vaccine maker Moderna over the course of last year, the Anglo-Swedish drugmaker’s latest annual report shows. The financial analysis is based on a comparison of the company's financial statements and evaluates the company's performance. Historical daily share price chart and data for AstraZeneca since 1993 adjusted for splits. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. The next Astrazeneca plc dividend went ex 20 days ago for 137.4p and will be paid in 12 days. AstraZeneca is an international biopharmaceutical company that produces and markets medicines used by millions of people around the world. The previous Astrazeneca plc dividend was 69.6p and it went ex 7 months ago and it was paid 6 months ago. Based on Moderna’s 2020 closing stock price of $104.47, a stake that size would be worth about $3.2 billion, Reuters calculations show. The company’s purpose and values include following science and putting patients first. AstraZeneca PLC (the Company) announced today the publication of its Annual Report and Form 20-F Information 2015 (Annual Report). AstraZeneca sold a stake it held in rival COVID-19 vaccine maker Moderna over the course of last year, the Anglo-Swedish drugmaker's latest annual report shows. With more than $24 billion in revenue in 2019 and 70,600 employees, the Cambridge-based drugmaker continues to rank among the largest drug companies in the world. This page shows a report that focusses on Financial Ratio Analysis of AstraZeneca and GlaxoSmithKline. Cambridge, England-based AstraZeneca’s vaccine being developed with Oxford University uses a weakened version of a chimpanzee common cold virus to deliver immunity-building proteins to the body. The latest closing stock price for AstraZeneca as of March 16, 2021 is 50.05.. ANNUAL FINANCIAL REPORT mån, mar 26, 2012 12:42 CET . AstraZeneca plc (/ ˌ æ s t r ə ˈ z ɛ n ə k ə /) is a British-Swedish multinational pharmaceutical and biopharmaceutical company with its headquarters in Cambridge, England. ANNUAL FINANCIAL REPORT. AstraZeneca’s stake in Moderna stood at 7.65% at the end of 2019, its annual report … London-listed AstraZeneca recorded $1.38 billion in equity portfolio sales last year, with “a large proportion” of it coming from the Moderna sale, according its latest annual report. Annual Financial Report Tue, Mar 08, 2016 13:04 CET. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income. AstraZeneca PLC Second Quarter and Half Year Results 2010 London, 29 July 2010 Revenue for the second quarter increased by 1 percent at constant exchange rates (CER) to $8,178 million. AstraZeneca has a portfolio of products for major disease areas including cancer, cardiovascular, gastrointestinal, infection, respiratory and inflammation. There are typically 2 dividends per year (excluding specials), and the dividend cover is approximately 1.3. AstraZeneca annual/quarterly revenue history and growth rate from 2006 to 2020. -Revenue in AstraZeneca PLC (the Company) announced today the publication of its Annual Report and Form 20-F Information 2011 (Annual Report); Notice of Annual General Meeting 2012 and Shareholders' Circular, together with a covering letter from the Chairman, and ‘AstraZeneca 2011 In Brief’. AstraZeneca’s stake in Moderna stood at 7.65% at the end of 2019, its annual report for that year showed.